clonidine has been researched along with m 35 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahrén, B; Bartfai, T; Gregersen, S; Land, T; Langel, U; Lindskog, S | 1 |
| Díaz-Cabiale, Z; Fuxe, K; González-Barón, S; Narváez, JA; Yanaihara, N | 1 |
2 other study(ies) available for clonidine and m 35
| Article | Year |
|---|---|
Blockade of galanin-induced inhibition of insulin secretion from isolated mouse islets by the non-methionine containing antagonist M35.
Topics: Amino Acid Sequence; Animals; Binding, Competitive; Bradykinin; Clonidine; Galanin; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Inbred Strains; Molecular Sequence Data; Neuropeptides; Peptide Fragments; Peptides; Somatostatin | 1993 |
Galanin/alpha2-receptor interactions in central cardiovascular control.
Topics: Adrenergic alpha-Agonists; Animals; Autoradiography; Binding, Competitive; Blood Pressure; Bradykinin; Cardiovascular Physiological Phenomena; Clonidine; Dose-Response Relationship, Drug; Galanin; Kinetics; Male; Peptide Fragments; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Galanin; Receptors, Neuropeptide; Solitary Nucleus; Specific Pathogen-Free Organisms; Tritium | 2000 |